$Exela Technologies (XELA.US)$ 阴跌不止

$Aterian (ATER.US)$ 下周将达到15

$PharmaCyte Biotech (PMCB.US)$
为什么换手率这么低？那些主要的参与者已经离开了这支股票吗？

$Aterian (ATER.US)$
当它到达7时，我一定会买更多。应该很快

$PharmaCyte Biotech (PMCB.US)$ 卖出。请降至2.5再让我进入。

$PharmaCyte Biotech (PMCB.US)$ 上上上到了

$PharmaCyte Biotech (PMCB.US)$ 向上向上

$PharmaCyte Biotech (PMCB.US)$ $Tilray Brands (TLRY.US)$ $Fate Therapeutics (FATE.US)$ One of the more notable companies to go public in August is PMCB, which owns the Cell-in-a-Box living Cell packaging platform for cancer and diabetes, and is developing cannabinoid-based drugs